We are live on
!
Find out more
RCA
Resonant Capital Advisors Portfolio holdings
AUM
$2.09B
1-Year Est. Return
20.07%
This Fund
S&P 500
This Quarter
Est. Return
+7.52%
1 Year Est. Return
+20.07%
3 Year Est. Return
+50.65%
5 Year Est. Return
+54.9%
10 Year Est. Return
–
AUM
$665M
AUM Growth
+$90M
(+16%)
Cap. Flow
+$49.9M
Cap. Flow
% of AUM
7.5%
Top 10 Holdings %
Top 10 Hldgs %
42.64%
Holding
213
New
23
Increased
145
Reduced
18
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marqeta
MQ
|
+$4.47M |
| 2 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$3.04M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$2.42M |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$2.28M |
| 5 |
Vanguard Dividend Appreciation ETF
VIG
|
+$2.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$2.87M |
| 2 |
Biogen
BIIB
|
+$995K |
| 3 |
CTXS
Citrix Systems Inc
CTXS
|
+$505K |
| 4 |
Exelixis
EXEL
|
+$280K |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$231K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.19% |
| 2 | Healthcare | 5.93% |
| 3 | Financials | 5.41% |
| 4 | Consumer Discretionary | 3.64% |
| 5 | Consumer Staples | 2.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Tesla
TSLA
$1.27T
| $393K | 0.06% |
+1,116
| New | +$374K |
|
152
Broadstone Net Lease
BNL
$4.07B
| $388K | 0.06% |
+15,644
| New | +$400K |
|
153
Elanco Animal Health
ELAN
$13.1B
| $388K | 0.06% |
13,680
+1,174
| +9% | +$36.5K |
|
154
iShares ESG Aware 1-5 Year USD Corporate Bond ETF
SUSB
$1.3B
| $383K | 0.06% |
14,936
| – | – |
|
155
Nuveen ESG Small-Cap ETF
NUSC
$1.33B
| $376K | 0.06% |
8,942
| – | – |
|
156
Universal Health Services
UHS
$10.4B
| $375K | 0.06% |
2,888
+283
| +11% | +$36.4K |
|
157
Netflix
NFLX
$309B
| $371K | 0.06% |
+6,150
| New | +$393K |
|
158
M&T Bank
MTB
$36.5B
| $364K | 0.05% |
2,372
+303
| +15% | +$46.5K |
|
159
Mondelez International
MDLZ
$79.9B
| $358K | 0.05% |
5,375
+539
| +11% | +$33.3K |
|
160
Merck
MRK
$317B
| $355K | 0.05% |
4,598
+1,120
| +32% | +$89.2K |
|
161
Icon
ICLR
$12.6B
| $344K | 0.05% |
1,109
| – | – |
|
162
Under Armour Class C
UA
$2.82B
| $343K | 0.05% |
+19,035
| New | +$370K |
|
163
Carrier Global
CARR
$53.9B
| $337K | 0.05% |
6,197
+310
| +5% | +$16.7K |
|
164
Zimmer Biomet
ZBH
$19B
| $332K | 0.05% |
2,691
+232
| +9% | +$30.4K |
|
165
Lam Research
LRCX
$385B
| $326K | 0.05% |
4,530
+310
| +7% | +$19.4K |
|
166
Vanguard ESG International Stock ETF
VSGX
$6.69B
| $323K | 0.05% |
5,216
| – | – |
|
|
EXAS
167
DELISTED
Exact Sciences
EXAS
| $321K | 0.05% |
+4,124
| New | +$364K |
|
168
Brown-Forman Class B
BF.B
$13B
| $317K | 0.05% |
4,347
+523
| +14% | +$37.2K |
|
169
Comcast
CMCSA
$87.8B
| $316K | 0.05% |
6,273
+42
| +0.7% | +$2.19K |
|
170
Neogen
NEOG
$2.49B
| $312K | 0.05% |
+6,872
| New | +$294K |
|
171
Linde
LIN
$226B
| $305K | 0.05% |
881
-194
| -18% | -$62.9K |
|
172
Broadcom
AVGO
$1.99T
| $303K | 0.05% |
+4,560
| New | +$256K |
|
173
Target
TGT
$67.1B
| $303K | 0.05% |
1,308
+212
| +19% | +$51.6K |
|
174
Direxion Daily S&P 500 Bear 1X ETF
SPDN
$224M
| $297K | 0.04% |
21,128
+2,749
| +15% | +$40.2K |
|
175
UnitedHealth
UNH
$375B
| $293K | 0.04% |
+584
| New | +$264K |
|
Similar funds
ACM
IHAM
CL
NSCM
ACG
NSUP
SFS
BWC
Resonant Capital Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, Resonant Capital Advisors held 213 positions worth $665M, up 16% from $575M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Resonant Capital Advisors deployed $49.9M of net new capital in Q4 2021, opening 23 new positions and adding to 145 existing holdings. Its largest new stake was Marqeta: 50,000 shares worth $3.43M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Xilinx Inc, an estimated $2.87M trimmed.
- Resonant Capital Advisors's largest Q4 2021 buy was Marqeta: 50,000 shares worth $3.43M.
- Resonant Capital Advisors added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2021, an estimated $3.04M increase.
- Resonant Capital Advisors's biggest Q4 2021 reduction was Xilinx Inc, cutting an estimated $2.87M.
- Resonant Capital Advisors fully exited Biogen in Q4 2021, selling an estimated $995K.
- Resonant Capital Advisors's ten largest holdings make up 43% of its $665M portfolio in Q4 2021.
- Resonant Capital Advisors opened 23 new positions and closed 9 in Q4 2021.
- Resonant Capital Advisors's portfolio value rose 16% quarter-over-quarter to $665M.
Based on Resonant Capital Advisors's 13F filing for Q4 2021, filed 26 Jan 2022.